p21-activated kinase (PAK) is a common eector protein of the small GTPases Cdc42 and Rac, leading to the activation of downstream mitogen activated protein kinases. PAK also mediates polarized cytoskeletal changes induced by these GTPases. The recently identi®ed PAK-interacting exchange factor (PIX) acts as a guanine nucleotide exchange factor on Rac, and colocalizes with PAK in a focal complex, but little is known about the associated signaling cascades, including upstream activators of PIX. In this study, we show that one of the isoforms of PIX, aPIX, is activated by signaling cascades from the platelet-derived growth factor (PDGF) receptor and EphB2 receptor, and from integrin-induced signaling through phosphatidylinositol 3-kinase (PI3-kinase). aPIX is activated by forming a complex with these receptors either via association with PAK and Nck, or direct association with the p85 regulatory subunit of PI3-kinase. Synthetic phosphoinositide and membrane targeted PI3-kinase augmented the aPIX activity in vivo. In Xenopus, aggregates of mesodermal cells derived from embryos microinjected with aPIX signi®cantly increased the peripheral spreading on ®bronectin substrate in response to PDGF through PI3-kinase. These results indicate that aPIX is activated by PI3-kinase, and is involved in the receptor mediated signaling leading to the activation of the kinase activity of PAK, and the migration of mesodermal cells on extracellular matrix.
Introduction
The p21-activated kinase (PAK) family of serine/ threonine kinases is known to be activated by binding to the GTP-bound form of Cdc42 or Rac1, small GTPases of the Rho family, and its activation leads to the activation of mitogen activated protein kinases (MAPK) (Brown et al., 1996; Zhang et al., 1995) . PAK also acts as a modulator of polarized cytoskeletal changes. For example, overexpression of bPAK induces a Rac phenotype including membrane ruing and lamellipodia formation, and membrane targeted PAK1 induces neurite outgrowth in PC12 cells (Obermeier et al., 1998; Daniels et al., 1998) . The correct conformation of the amino terminus and a proline-rich region of PAK1 is important in the regulation of polarity of the cytoskeleton. A PAK1 construct with a modi®ed amino terminus, which was more accessible to SH3 proteins such as Nck, had dramatic eects on the formation of polarized membrane rues and focal complexes, while the same construct with an additional mutation in the prolinerich region to abolish binding ability to SH3 protein showed no eect (Sells et al., 1997) . For wild-type PAK1, equivalent conformational changes presumably occur in vivo upon binding to activated Cdc42 and Rac1. PAK likely binds to an SH3 domain-containing protein which interacts with F-actin, and eventually contributes to the regulation of cell morphology in Saccharomyces cerevisiae (Leeuw et al., 1995) .
Recently, the PAK-interacting exchange factor (PIX) family, which are Rho-p21 guanine nucleotideexchange factors (GEF), have been identi®ed . The human PIX family, which consists of two isoforms (a-and bPIX), bind tightly through an N-terminal SH3 domain to a conserved proline-rich PAK sequence located at the C-terminus of p21-binding domain (PBD) , and are colocalized with PAK to form activated Cdc42-and Rac1-driven focal complexes Oh et al., 1997) . Recently, it was demonstrated that the association of the PAK amino terminus with the PIX SH3 domain resulted in activation of PIX GEF function toward Rac, which leads to Rac-type morphological eects (Obermeier et al., 1998) .
However, little is known about the signaling cascades in which PIX is involved, and how PIX is activated. It has been shown that the adapter protein Nck links receptor tyrosine kinases to downstream signaling pathways in association with tyrosinephosphorylated receptors via its Src homology 2 (SH2) domain, and proline-rich sites on target proteins including PAK via its SH3 domains Galisteo et al., 1996) . Therefore, PAK1 may associate with both Nck and PIX, as Nck and PIX binds to dierent sites among the three proline-rich regions of PAK . These ®ndings suggest that PIX might be involved in signaling cascades from receptor tyrosine kinases. Together with Nck, PAK may function as a scaolding protein linking PIX to receptors locating at the cell membrane, which results in activation of PIX. PDGF-stimulation of cells is known to induce active cytoskeletal rearrangement, and endogenous PAK1 redistributes into membrane rues and edges of lamellipodia. The ®ndings that such changes induced by PDGF are prevented by the phosphatidylinositol 3-kinase inhibitor wortmannin, may indicate that PI3-kinase has a key role in the regulation of cytoskeletal changes mediated by GTP-ases (Hawkins et al., 1995) .
We have isolated cDNAs encoding human a-and bPIX which were later revealed to be identical to KIAA0006 and KIAA0142 in GenBank, respectively, from a gastric cancer cell cDNA library. In this report, we show that aPIX is a more eective GEF than bPIX toward Rac1 and also Cdc42, and that it subsequently activates PAK kinase under PDGF stimulation. aPIX mediates signals initiated from the receptor tyrosine kinases of PDGFR and EphB2. It also transduces the signal from cell adhesion to ®bronectin substratum, leading to PAK kinase activation. These eects of aPIX were inhibited by coexpression of a mutated p85 regulatory subunit of PI3-kinase, which was expected to abolish its binding to the catalytic subunit of PI3-kinase. Moreover, aPIX-induced PAK kinase activation was at least partially inhibited by Nck with an SH2 domain mutation.
In Xenopus, PDGF stimulates aggregates of embryonic mesoderm cells to spread on ®bronectin substrate, and this is dependent on PI3-kinase activity (Symes and Mercola, 1996) . Microinjection of RNA encoding aPIX into Xenopus embryos strongly activated PDGF signaling through PI3-kinase and induced spreading of mesodermal cell aggregates peripherally on ®bronectin. These results suggest that aPIX is activated by recruitment to phosphorylated receptor tyrosine kinases or a focal complex either by the formation of a complex with PAK and Nck, or direct association with p85. We conclude that aPIX is a target protein of PI3-kinase associated with these receptors, which can activate PAK kinase activity and induce signi®cant morphological changes.
Results and discussion
aPIX mediates signals from receptor tyrosine kinases leading to PAK1 activation
We examined whether PIX mediates signals initiated from receptor tyrosine kinases and integrin signals from cell adhesion to ®bronectin substrate. In vivo and in vitro experiments indicate that Nck can mediate the relocalization and subsequent activation of PAK1 kinase , and can also mediate signals Figure 1 aPIX facilitates signaling from PDGF receptor and EphB2. (a) Schematic representation of wild-type and truncated PIX cDNA constructs. Proteins are depicted to scale; CH, calponin homology; SH3, Src homology 3; DH, dbl homology; PH, pleckstrin homology; Pro, proline-rich region. (b and c) 293T cells were transfected with plasmids encoding PDGFRb (b) or EphB2 (c); Nck, myc-tagged PAK1, wild-type or mutated forms of aPIX with or without Nck R308K, Dp85 as indicated above the lanes. Forty-eight hours later, cells were lysed for immunoprecipitation and an in vitro kinase assay for PAK1 was performed. Before making cell lysates, transfected cells (b) were treated (+), or untreated (7) with PDGF BB. Lane 11; transfected cells were incubated for 25 min with 100 nM wortmannin before being treated with PDGF. The number in the ordinate (b; lanes 1 ± 6, c; lanes 1 ± 5) indicates the relative PAK1 kinase activity as a fold of the activity present in cells lacking PIX (lane 2). Similar results were obtained in three independent experiments. phospho-MBP, phosphorylated-myeline basic protein aPIX is activated by phosphatidylinositol 3-kinase S Yoshii et al from PDGFR and EphB2, which is a member of Eph family receptor tyrosine kinases whose signal cascade is poorly understood, to MAPK (Stein et al., 1998; Holland et al., 1997; Meisenhelder and Hunter, 1992; Nishimura et al., 1993) . Therefore, in our experiment, the kinase activity of PAK was measured under the activation of these receptors in cells coexpressing PAK and Nck with wild-type or various truncated mutants of human aPIX (Figure 1a) . Without ligand stimulation, PAK1 was not adequately activated by transfection of any form of aPIX with or without Nck (data not shown). We performed the experiments under the condition that PAK1 was weakly activated by stimulation of ligands in the absence of PIX ( Figure  1b and c, lanes 1 and 2) . Wild-type as well as Nterminal deleted aPIX (DCH) enhanced kinase activity of PAK1 in PDGF-stimulated cells (Figure 1b, lanes 3  and 4) . In contrast, SH3 domain-or PH domaindeleted aPIX showed very little eect to activate PAK1 (Figure 1b , lanes 5 and 6). Coexpression of Nck carrying a mutation in the SH2 domain (R308K), which lacks the ability to bind phosphorylated receptors, inhibited the PAK activation by aPIX in PDGFR-stimulated cells (Figure 1b , lane 8). The PAK1 activation by aPIX was also disrupted by the coexpression of the p85a subunit of phosphatidylinositol 3-kinase (PI3-kinase) with a mutation that blocks binding to the p110 catalytic subunit of PI3-kinase (Dp85) (Figure 1b, lane 9) , or treatment of the cells with wortmannin, which inhibits PI3-kinase activity at low concentrations (Yano et al., 1993; Arcaro and Wymann, 1993; Kanai et al., 1993) (Figure 1b , lane 11). These results indicate that aPIX function in the signaling pathway from PDGFR to PAK1 activation requires interaction with Nck and PI3-kinase.
Transiently expressed EphB2 in Cos cells is phosphorylated on tyrosine residues, including a residue crucial to the interaction with the SH2 domain of Src (Zisch et al., 1998) . In 293T cells, exogenously expressed EphB2 is also highly phosphorylated on tyrosine residues, and activates MAP kinase family proteins, including extracellular signal-stimulated kinase (erk1) and c-Jun NH 2 -terminal kinase (JNK) (data not shown). Coexpression of aPIX also enhanced PAK1 activation in EphB2 receptor-expressing 293T cells (Figure 1c , lanes 3 and 4), which was inhibited by Dp85, and partially inhibited by Nck R308K ( Figure  1c , lanes 7 and 8). These results suggest that aPIX is involved in the signaling pathway from EphB2 to activation of PAK1 kinase activity. While this manuscript was in preparation, Daniels et al. (1999) reported truncated form aPIX 155 ± 545 , but not wild-type aPIX activated PAK kinase in Cdc42-overexpressed cells. We also detected much higher PAK1 kinase activity by DCH aPIX than by wild-type aPIX in cells cotransfected with PAK and Cdc42 (data not shown). However in PDGF or EphB2-stimulated cells, we could detect activation of PAK also by wild-type aPIX. Some conformational changes which lead to the full activation of aPIX may explain this observation.
Next, we tested the interaction of aPIX with Nck and these receptors in vivo by immunoprecipitation. As shown in Figure 2a (lane 2), aPIX formed a complex with the PDGF receptor, Nck and PAK1 in PDGFtreated cells. Likewise, aPIX associated with activated EphB2 tyrosine kinase receptor under the coexpression of Nck and PAK1 (Figure 2a, lane 5) . The association of aPIX with these receptors at least partially depends on the expression of Nck and PAK1, because coexpression of PAK carrying a mutation in the ®rst proline-rich region which impaired its binding to the Nck SH3 domain (P13A-PAK1) inhibited the associa- aPIX is activated by phosphatidylinositol 3-kinase S Yoshii et al tion of aPIX with these receptors (Figure 2a , lanes 3 and 6). These results also indicate that aPIX does not directly associate with Nck, but forms a complex with Nck and the receptors via PAK. Moreover, as shown in Figure 2b , wild-type p85a subunit of PI3-kinase, but not p85a 330 ± 724 (p85(III)) associates with PIX directly in vivo (lanes 2, 3 and 4) and in vitro (lanes 5 and 6). This implies that PIX binds to the N-terminal region upstream of the ®rst SH2 domain of the p85 subunit, while SH3 domain of PIX is not involved in the association with p85. This is not the case with the Rac1-speci®c GEF, Vav. Tyrosine-phosphorylated Vav forms a complex with the p85 subunit of PI3-kinase via its SH2 domain (Shigematsu et al., 1997) . We could also detect the association of p85 subunit with PAK1 in vivo, although its interaction was weak ( Figure 2b , lane 1). Although little is known about the proteins that interact with EphB2, the SH2 domain of p85 is reported to associate with autophosphorylated EphB2 in vitro (Holland et al., 1997) . We also detected the association of p85 with phosphorylated EphB2 in vivo ( Figure 2b , lane 7). However, we cannot currently determine whether the phosphorylated tyrosine residues of EphB2 in this experiment are identical to those stimulated by the physiological interaction with ligandexpressing cells, because the association of Nck and EphB2 was weak in this experiment, comparing to that when cells which stably express EphB2 receptor were cocultured with cells stably expressing EphrinB1, a ligand for EphB2 (data not shown). This observation may explain why Nck R308K only partially inhibited PAK activation by aPIX in EphB2-expressing cells (Figure 1c, lane 8) .
We propose that there are two ways by which aPIX may be recruited to the activated receptors where PI3-kinase is located. Recruitment of the aPIX-PAK-Nck complex to the activated receptors may result in colocalization of this complex with PI3-kinase. Alternatively, aPIX may also be recruited to the tyrosine-phosphorylated receptors by the direct asso- Figure 3 aPIX activates Rac1 and Cdc42 by PDGF stimulation. (a) 293T cells were cotransfected with plasmids encoding PDGFRb, wild-type p85, DCH aPIX indicated above the lanes and wild-type Cdc42 (lanes 1, 2, 3 and 4) or Rac1 (lanes 5, 6, 7 and 8). aPIX(7) indicate mock vector pCS2+ DNA was transfected to adjust the total amount of transfected DNA per dish. Cells were treated(+) or untreated(7) with PDGF BB, and lysed for anity-precipitation (AP) with immobilized GST-PBD as described in Materials and methods. Precipitated GTP-bound p21 was detected by immunoblotting with anti-Cdc42 (lanes 1, 2, 3 and 4) or Rac1 (lanes 5, 6, 7 and 8) antibody. (b) 293T cells were transfected with plasmids encoding PDGFRb, DCH, aPIX, myc-tagged PAK1, pEBG-Cdc42 and wild-type (WT) or mutated (R308K) Nck indicated above the lanes and treated with PDGF BB (lanes 2 ± 5). Cells in lane 5 were also transfected with Dp85. Cells were lysed in the same buer as in (a) and rapidly precipitated by incubation with glutathione-sepharose for 30 min at 48C. After washing three times with same lysis buer, bound proteins were Western blotted and probed with anti-myc antibody. GTP-bound Cdc42 in cell lysates was evaluated by detection of coprecipitated PAK1 protein. Precipitated GST-Cdc42 and the expression level of PAK1 and PDGFR in each total cell lystate were shown at the bottom. (c) 293T cells were transfected with plasmids encoding PDGFRb, Nck, myc-tagged PAK1, pEBG-Rac1 (lanes 1, 2 and 3) or pEBGCdc42 (lanes 4, 5 and 6), and mock vector, wild-type a-or bPIX. Cells were treated with PDGF BB before lysis and then precipitated with glutathione-sepharose as in (b). Coprecipitated PAK1 protein was Western blotted and detected by anti-myc antibody. (d) Eects of aPIX and bBIX on [ciation with the p85 subunit of PI3-kinase. Consistent with this model, coexpression of p85 resulted in an increase in those receptors that coprecipitated with aPIX even under when the complex formation of aPIX with PAK and Nck was inhibited (Figure 2c , lanes 2 and 4). We also examined Rac1 or Cdc42 activation by aPIX in vivo by anity precipitation of GTP-bound Rac or Cdc42 with GST fusion protein of the p21 binding domain of PAK1 (GST-PBD) as described (Bagrodia et al., 1998) . Under PDGF-treatment, there was an increase in the amount of activated Rac1 and Cdc42 that precipitated with GST-PBD in aPIXtransfected 293T cells compared with that in vectortransfected control cells (Figure 3a) . Furthermore, the mutants of Nck (R308K) and p85 (Dp85) inhibited the aPIX-induced activation of Cdc42, which was determined by the rapid precipitation of PAK associated with GTP-bound Cdc42 in cell lysates containing high concentrations of Mg 2+ as described in the legend (Figure 3b, lanes 4 and 5) . The ability of aPIX to promote guanine nucleotide exchange toward p21 in vivo was also reproducibly higher than that of bPIX (Figure 3c ). Further experiments including the comparison of the degree of activation of PAK by a-, or bPIX and the other GEF, such as Dbl and Vav, might be necessary to evaluate the signi®cance of PIX in this signaling pathway. We have also detected the stimulation of [ 3 H]GDP dissociation from Cdc42 in vitro by aPIX in contrast to the decreased ability of bPIX to catalyze the GDP dissociation (Figure 3d) . aPIX, but not bPIX also stimulated the GDP dissociation from Rac1, although less eciently than aPIX toward Cdc42 (data not shown). This modest eect of bPIX (Cool-1) was also reported elsewhere recently (Bagrodia et al., 1998) .
aPIX mediates the signal leading to PAK activation by cell adhesion to ®bronectin substratum Integrin-mediated cell adhesion to ®bronectin leads to tyrosine phosphorylation of several proteins associated with the focal complex, such as focal adhesion kinase (p125 FAK ) and p130 cas and activates MAP kinase by interacting with c-Src, Grb2 and Nck (Schlaepfer et al., 1997) . We examined whether PIX is also involved in the ®bronectin-induced signaling cascade of PAK activation through interactions with Nck and/or PI3-kinase. Expression of aPIX enhanced PAK1 kinase activity in cells plated on ®bronectin-coated dishes (Figure 4a, lanes 3 and 4) . Moreover, ®bronectin-dependent PAK1 activation by aPIX was remarkably reduced by the coexpression of Dp85 or Nck carrying a mutation in its SH2 domain as well as dominant negative Rac1 or Cdc42 (Figure 4a, lanes 8 ± 11) . To con®rm that the association with aPIX is required for the activation of PAK1, PAK1 with mutation which abolished its binding ability with PIX (PAK1 P191G,R192A) was used . Compared to the strong activation of wild-type PAK, PAK1 (P191G,R192A) was not activated in the presence of aPIX when transfected cells were plated on ®bronectin (Figure 4a, lanes 15 and 16) . These results indicate an essential role for aPIX in PAK1 activation by ®bronectin. Tyrosine-phosphorylated p125 FAK directly binds to the p85 subunit of PI3-kinase, which subsequently activates PI3-kinase (Chen et al., 1996) . Under stimulation of ®bronectin, aPIX formed a complex with p125 FAK and p130 cas in cells (Figure 4b, lanes 1 and 4) . As in the case of stimulation by PDGFR or EphB2, association with PAK and Nck, as well as with p85 is considered to be important for this pathway of activation of aPIX.
In contrast, when the eect of aPIX was examined on PAK1 activation by exogenous stress including DNA damage induced by cisplatinum, PIX had no eect (Figure 4c ). aPIX did not enhance the level of PAK1 kinase activity induced by cisplatinum. This result might be consistent with the ®nding that we could not detect the eective inhibition of PAK1 kinase activity by coexpression with T17N Rac1 or T17N Cdc42 in cells treated with cisplatinum (data not shown).
These results indicate aPIX involvement in PAK activation is limited to signaling cascades from receptor tyrosine kinases and cell adhesion to ®bronectin. In conclusion, two ways for relocalization of aPIX to tyrosine-phosphorylated sites of receptors and proteins associated with the focal complex were identi®ed; complex-formation with Pak and Nck, or direct association with p85.
aPIX is activated by the lipid products of PI3-kinase
The results that PAK1 activation by aPIX was blocked by coexpression of Dp85 described above demonstrate that the activity of aPIX may depend on the interaction with PI3-kinase which is localized at the activated receptors. We next examined whether aPIX is activated by the membrane-targeted p110 catalytic subunit of PI3-kinase. aPIX was cotransfected into 293T cells with the p110 subunit of PI3-kinase with the addition of a myristoylation signal at amino terminus (myr p110) together with wild-type p85. The membrane-localized p110 (myr p110) is known to be sucient to trigger PI3-kinase dependent signals including the activation of p70 S6 kinase and Akt (Klippel et al., 1996) . Myristoylated p110 activated wild-type and DCH aPIX, which was detected by the increased amount of GTP-bound Rac1 in vivo ( Figure  5a , lanes 4 and 5). In contrast, as expected aPIX lacking the PH domain (DPH) was not activated by the Figure 5 aPIX is activated by PI3-kinase. (a) Membrane localized PI3-kinase activated aPIX. 293T cells were transfected with plasmids encoding wild-type Rac1, p85, N-terminal myristoylated p110 subunit of PI3-kinase (myr p110), wild-type or mutants of aPIX, bPIX, or mock vector as indicated above the lanes. Cells were lysed and anity-precipitated (AP) with immobilized GST-PBD. Precipitated GTP-bound Rac1 was detected by immunoblot with anti-Rac1 antibody, lanes 1 and 2 (7); control cells without transfection of p110. (b) Lipid products of PI3-kinase activated aPIX in vivo. Plasmids encoding wild-type Rac1, p85, myr p110 and DCH or DPH aPIX were transiently transfected into 293T cells. aPIX(7) indicate mock vector pCS2+ DNA was transfected to adjust the total amount of transfected DNA per dish. Cells were treated(+) or untreated (7) with DiC 16 PI-3,4,5-P 3 at a concentration of 10 mM for 20 min before making cell lysates for anity-precipitation with immobilized GST-PBD. Precipitated GTP-bound Rac1 was detected by immunoblot with anti-Rac1 antibody. Expression of PIX and Rac1 in each cell lysate were shown at the bottom. DiC 16 PI-3,4,5-P 3 dipalmitoyl phosphatidylinositol-3,4,5-trisphosphate. (c) Measurement of the dissociation of [ coexpression with myristoylated p110 (Figure 5a , lane 6). Moreover, bPIX showed less activity than wild-type aPIX to activate Rac1 in response to coexpression with myristoylated p110 (lane 9), although bPIX also associated with p85 and was thought to be translocated to the cell membrane by myr p110 in vivo (data not shown).
To con®rm that aPIX is a target protein of PI3-kinase, we examined whether aPIX is also activated by the lipid products of PI3-kinase. As an example, Vav is fully activated by binding of phosphatidylinositol-3,4,5-triphosphate (PI-3,4,5-P 3 ) or another lipid product of PI3-kinase to the PH domain of Vav (Han et al., 1998; Gringhuis et al., 1998) . Although aPIX may be translocated to the cell membrane and interact with phospholipid products via its PH domain, such direct relocalization of aPIX by the PH domain itself may not be the major mechanism of receptor mediated activation of aPIX, because coexpression with mutated forms of Nck (Nck R308K) or p85 (Dp85) inhibited aPIX activation despite the presence of an intact PH domain. Therefore, activation of aPIX by treatment of the cells with phospholipids was examined under conditions in which aPIX is recruited to the cell membrane by the coexpression with myr p110 and p85. PI-3,4,5-P 3 did not stimulate Rac1 in the absence of PIX (Figure 5b , lanes 1 and 2). As shown in Figure 5b , DCH aPIX was synergistically activated by the expression of myristoylated p110 and the treatment of cells with PI-3,4,5-P 3 , resulting in an increase in the GTP-bound form of Rac1. Without expression of myr p110, activation of aPIX by the treatment of cells with PI-3,4,5-P 3 was weak, and we also detected the synergistic eect of myristoylated p110 and PI-3,4,5-P 3 on wild-type aPIX (data not shown). In contrast, the activity of aPIX lacking the PH domain was not aected by the phospholipid (Figure 5b, lanes 5 and 6) . These results indicate aPIX is activated by PI3-kinase through binding of the lipid product of PI3-kinase (PI-3,4,5-P 3 ) to the PH domain of aPIX. The activation of exchange activity of aPIX 153 ± 545 by PI-3,4,5-P 3 in vitro was also detected by the examination of [ 3 H]GDP dissociation from Cdc42. However, the eect of PI-3,4,5-P 3 itself was not so great (Figure 5c ). It is possible that other regions of aPIX may be required for the full activation of aPIX by PI-3,4,5-P 3 , or other molecules locating at cell membrane may modify the conformation of PIX and activate it. Alternately PHdomain-deleted construct has other negative eects and suppresses background exchange activity.
aPIX activates PDGF-induced spreading of Xenopus mesoderm aggregates on ®bronectin substratum
We further analysed whether aPIX is involved in PDGF-stimulated signaling to modify cell movement on extracellular matrix by using a system of involuting mesodermal cells in gastrula-stage Xenopus embryos. Migration of mesoderm cells over the ®bronectin-rich inferior surface of the blastocoel is known to be important for gastrulation and subsequent anteriorposterior neural patterning of the embryo (Keller and Jansa, 1992) . PDGF-A is a candidate signaling molecule involved in gastrulation (Jones et al., 1993) During Xenopus gastrulation, PDGF receptor-a is expressed in involuting marginal zone cells which migrate over ectodermal cells expressing PDGF-A (Ataliotis et al., 1995) . To examine the ability of aPIX to modify PDGF-induced mesodermal cell movement, we used an in vitro assay in which mesoderm cell aggregates spread on ®bronectin when exposed to PDGF-A, but form dense clumps in the absence of PDGF-A (Symes and Mercola, 1996) . We microinjected mRNA encoding aPIX together with mRNA encoding human PAK1 into marginal zones of the two dorsal blastomeres in four-cell stage embryos. Dorsal marginal zone (DMZ) aggregates, which also contain some endodermal cells, from embryos coinjected with aPIX and PAK1 formed ®lopodia and spread peripherally on ®bronectin substratum, while control embryos microinjected with wild-type PAK1 alone showed less spreading of DMZ aggregates (Figure 6a and b) . Microinjection of aPIX mRNA alone also stimulated the peripheral spreading compared to the control, but was always less eective than coinjection with PAK1 mRNA (data not shown). Without PDGF-stimulation, aggregates expressing both aPIX and PAK1 did not show any peripheral spreading. The ability of aPIX to stimulate PDGFdependent peripheral spreading of mesodermal aggregates on ®bronectin was independent from kinase activation of PAK, as coinjection of kinase-activated PAK1 plus aPIX also induced aggregate spreading to almost the same degree as with coinjection of wild-type PAK1 (Figure 6c ). This observation is consistent with the previous report that a PAK1 mutant which does not have an active catalytic domain also showed dramatic eects on the polarity of the cytoskeleton in ®broblast cells (Sells et al., 1997; Obermeier et al., 1998) . Furthermore, microinjection of PAK1 with mutation in its p21-binding domain (PAK1 H83L,H86L), which lacks the binding ability to GTP- Figure 7 Integrated models for the PDGFR, EphB2 and integrin-induced signaling cascades, which are mediated by aPIX. (a) Upon engagement of the receptors by ligands, the tyrosine residues in the cytoplasmic domain of the receptors are autophosphorylated. The SH2 domains of the p85 subunit of PI3-kinase bind to phosphotyrosine residues of the receptors. aPIX associates with p85, which serves to recruit aPIX to the complex. aPIX is also recruited to the complex by the subsequent association with PAK and Nck. Upon ligation of the receptors, the kinase activity of the p110 subunit of PI3-kinase is activated, which generates phosphoinositides including PI-3,4,5-P 3 . (b) Upon binding of phosphoinositide (PI) to the PH domain of aPIX, aPIX is fully activated, possibly by a conformation change, and activates Rac1/Cdc42 leading to the activation of PAK, or cytoskeletal rearrangement. To clarify this, the same scheme is presented for both receptors, although the phosphorylation site of EphB2 which serves as a binding site for p85 is not known, and EphB2 has only one catalytic domain in the cytoplasmic region. TK, tyrosine kinase domain. (c) Integrin receptor engaged with ®bronectin stimulates p125 FAK autophosphorylation, which creates the c-Src SH2 domain binding motif. Src family proteins associated with p125 FAK can potentiate tyrosine phosphorylation of p130 cas , which provides SH2 binding sites for the Nck. On the other hand, the SH2 domains of the p85 subunit bind to other phosphotyrosine residues of the p125 FAK . Thus, aPIX is recruited to the complex by either subsequent association with PAK and Nck, or association with the p85 subunit, following the activation of Rac1/Cdc42 as described above aPIX is activated by phosphatidylinositol 3-kinase S Yoshii et al p21, also showed the similar eect with wild-type PAK on the spreading of mesoderm aggregates (data not shown). From this result, we can rule out the possibility that association of PAK with GTP-p21 protected Rac1/Cdc42 from GAPs, thus induced mesoderm aggregates spreading. In contrast, coinjection of dominant-negative mutants of Rac1, or pretreatment of dorsal marginal zone cells with wortmannin inhibited the spread of aggregates on ®bronectin under PDGF treatment (Figure 6d and e) . These results suggest that aPIX activation by PDGFtreatment also occurs in the mesodermal cells of DMZ presumably via PI3-kinase. In previous reports, PI3-kinase may also act as an eector protein of activated GTPase to spread mesodermal aggregates on fibronectin, as GTP-Rac and GTP-Cdc42 bind to p85 and are proposed to activate PI3-kinase directly (Zheng et al., 1994; Tolias et al., 1995) , and Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI3-kinase (Keely et al., 1997) . Therefore, it is likely that aPIX and PI3-kinase constitute a positive feedback. When interpreting our observations, we cannot exclude the possibility that aPIX may have changed the dorso-ventral fate of mesodermal cells resulting in alteration of the expression level of PDGF receptor or integrin. Although spreading of mesoderm aggregates on ®bronectin by PDGF-treatment was reported to depend on the activity of PI3-kinase, its signi®cance in the signaling cascade is not known. Further experiments will be necessary including analysis of the morphological changes (i.e. membrane ruing) of dispersed-single cells of aPIX-injected marginal zone mesoderm to determine whether the eect of aPIX on the spread of mesoderm aggregates described above is completely relevant to the actinorganization eect of Rac1.
Based on our experiments, aPIX is likely to be a crucial regulator of the actin cytoskeleton involved in cell motility and invasiveness induced by the tyrosine kinase receptors such as PDGFR. We have demonstrated that aPIX is also a target protein of PI3-kinase associated with the receptors. Therefore, there are at least two ways for recruitment of aPIX to the receptors; direct association with p85, or association with PAK and Nck (Figure 7) . In a recent report, a PAK-PIX interaction led to PIX activation, and PAK was suggested to act upstream of Rac-mediated morphological changes through interaction with PIX (Obermeier et al., 1998) . Our ®nding that association of PIX with PAK and Nck resulted in relocation of PIX to receptors at the cell membrane might support this model. Activated p21 associates with PAK, and may change N-terminal conformation of PAK to a more accessible shape for aPIX binding, which would form a positive feedback for these molecules. Daniels et al. (1999) reported recently that PAK1 mutant that does not bind Rac or Cdc42 is activated in the absence of GTPase by truncated form of aPIX and proposed an exchange factor-independent mechanism of PAK activation by PIX. There is also a possibility that binding of PAK to PIX directly changes the conformation, and results in activation of PIX and PAK each other.
It is also tempting to speculate that activated aPIX may lead to oncogenic transformation as well as invasiveness and metastasis of tumors due to its eects on cytoskeletal organization and cell motility on extracellular substratum. The determination of the role of aPIX itself in early embryonal development may require another series of experiments.
Materials and methods

Plasmids and antibodies
Plasmids encoding full-length cDNAs of human aPIX and bPIX were gifts from T Nagase (KIAA0006 and KIAA0142, respectively). Deletion mutants of PIX tagged with a myc epitope at the C-terminus were generated using a PCR-based technique (Tanaka et al., 1997) . All constructs were subcloned into the pCS2+ vector for transfection into 293T cells, into pGEX2T (Pharmacia) to make bacterial GST fusion constructs, and into pGHXP (a derivative of pGEM-HE, a gift from L Zon) to make mRNA for microinjection into Xenopus embryos. pGEX-PBD was generated by cloning of a PCR-ampli®ed fragment of putative Cdc42 and the Rac binding domain of human PAK1 (amino acids 70 ± 133) into pGEX2T for anity precipitation. Plasmid encoding full-length cDNA of mouse EphB2 was a gift from T Pawson. Amino-terminal myctagged wild-type and mutant (P13A, K299R and H83L H86L) human PAK1 clones, wild-type and mutant (R308K) Nck clones, and wild-type and mutant (T17N) clones of Cdc42, Rac1 and RhoA were kindly provided by Bruce J Mayer Tanaka et al., 1995) . PAK1 (P191G,R192A) tagged with myc epitope at the C-terminus was generated and cloned into the pCS2+ vector. Wild-type and mutated forms (Dp85, p85(III)) of bovine p85a, and p110 subunit of PI3-kinase with myristoylation signal (myr p110) were provided by W Ogawa (Yonezawa et al., 1992; Hara et al., 1994) . Plasmid encoding p130 cas was provided from H Hirai (Nakamoto et al., 1996) , and chicken p125
FAK from JT Parsons. The monoclonal antibody for Nck was from Transduction Laboratories. The monoclonal antibodies for the myc epitope tag and HA epitope tag were from Santa Cruz and Berkeley Antibody Co., respectively. Polyclonal antibodies for Cdc42 and Rac1 were from Santa Cruz, and PDGF type B receptor was from Upstate Biotechnology. Rabbit polyclonal serum for mouse EphB2 was a gift from EB Pasquale.
Cell culture, transfections and in vitro kinase assay 293T human embryonal kidney cells (expressing simian virus 40T antigen) were transfected with a maximum of 20 mg of plasmid DNA per 10 cm diameter dish by a calcium phosphate coprecipitation method with concurrent treatment with 25 mM chloroquine essentially as described previously (Tanaka et al., 1995) . At 18 ± 24 h after transfection, cells were placed in medium with 0.5% FBS and incubated for a further 12 h. Cells were either untreated or treated with human, recombinant PDGF-BB (Sigma) at ®nal concentration 40 ng/ml for 15 min prior to lysis. For ®bronectin stimulation, transfected cells were plated onto culture dishes coated with human plasma ®bronectin (Gibco BRL) for 30 min. For treatment of transfected cells with synthetic dipalmitoyl phosphoinositides, phosphatidylinositol 3-phosphate (DiC 16 PI3-P), phosphatidylinositol-3,4-bisphosphate (DiC 16 PI-3,4-P 2 ) or phosphatidylinositol-3,4,5-trisphosphate (DiC 16 PI-3,4,5-P 3 ) (Matreya, Inc.) was sonicated and added to the medium at a concentration of 10 mM for 20 min as described (Derman et al., 1997) . Cells were harvested for immunoprecipitation and kinase assays as previously described (Tanaka et al., 1995) . To purify myc-tagged PAK protein, monoclonal antibody against myc epitope (1 mg) was incubated with 500 ml cell lysate for 2 h at 48C and precipitated with protein G-agarose (Boehringer MannaPIX is activated by phosphatidylinositol 3-kinase S Yoshii et al heim). Immunoprecipitates were washed extensively before immunoblotting or in vitro kinase assay with MBP as substrate. The results were visualized by Bio Imaging Analyzer (BAS1000 Fuji), and the image was quantitated with NIH Image software. The relative activity of PAK was calculated by adjusting the densitometric value and standardization.
In vitro association of HA-p85 with GST-PIX 293T cell lysates transiently expressing p85 tagged with HA epitope at the amino-terminus were prepared as described above. Immobilized GST-bPIX was incubated with cell lysates for 4 h at 48C. Precipitates were washed three times with lysis buer, and bound proteins were eluted in sample buer subjected to SDS ± PAGE, Western blotted, and probed with anti-HA mAb.
